2000
DOI: 10.1002/1098-2744(200007)28:3<168::aid-mc5>3.0.co;2-e
|View full text |Cite
|
Sign up to set email alerts
|

Promotion of Hepatocarcinogenesis by Phenobarbital in c-myc/TGF-? Transgenic Mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

2002
2002
2010
2010

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 10 publications
(11 reference statements)
0
5
0
Order By: Relevance
“…Moreover, our observations further validate previous reports that MYC can cooperate with agents that modulate the liver and thereby stimulate hepatocyte proliferation. Most notably, MYC has been shown to cooperate with TGF-alpha and phenobarbital to induce accelerated tumorigenesis in the adult murine liver [37]. Our model recapitulates the latency of tumor formation associated with adult onset HCC.…”
Section: Discussionmentioning
confidence: 55%
“…Moreover, our observations further validate previous reports that MYC can cooperate with agents that modulate the liver and thereby stimulate hepatocyte proliferation. Most notably, MYC has been shown to cooperate with TGF-alpha and phenobarbital to induce accelerated tumorigenesis in the adult murine liver [37]. Our model recapitulates the latency of tumor formation associated with adult onset HCC.…”
Section: Discussionmentioning
confidence: 55%
“…For instance, growth of preneoplastic lesions, at least in early stages, has been ascribed to proliferative activity, but apoptosis was either not studied (Hanigan et al, 1988;Pereira, 1993) or did not exhibit a significant role for growth of preneoplasia (Goldsworthy and Fransson-Steen, 2002;James and Roberts, 1996;Kamendulis et al, 2001;Stevenson et al, 1999). Other studies reported apoptosis-inhibition by tumor-promoting agents (phenobarbital, peroxisome proliferators) as important determinants for tumor development in mice (James et al, 1998;Sanders and Thorgeirsson, 2000). Moreover, we have found that normal mouse hepatocytes do not undergo apoptosis as readily as rat hepatocytes in response to signals inducing regression of the liver (Bursch et al, accompanying manuscript;Chabicovsky et al, 2003;Parzefall et al, 2002).…”
mentioning
confidence: 75%
“…Although the exact mechanism by which Smad3 deletion blocks TGF-␣ overexpression remains to be determined, it is likely that loss of Smad3 abrogates TGF-␀1-induced TGF-␣ overexpression, consequently perturbing the autoinduction of TGF-␣ expression. TGF-␣ is overexpressed in many cancer types and functions as a potent mitogen for cancer cell proliferation (61,62). In addition, TGF-␣ is a critical survival factor against apoptosis for cancer cells (37,38).…”
Section: Discussionmentioning
confidence: 99%